It has been reported in previous studies that, in myeloproliferative neoplasms, the presence of a Janus kinase 2 (JAK2) mutation is associated with an increase in free oxygen radicals and, consequently, DNA damage is increased [15]. The gene discussed is JAK2; the disease is myeloproliferative disorder.